In addition, some researchers found that EPHB2 kinase expression is elevated in sorafenib-resistant HCC cells, and this kinase regulates cancer stemness and drug resistance through the TCF1/EPHB2/β-catenin positive feedback loop. The gene discussed is EPHB2; the disease is hepatocellular carcinoma.